ASX Share rice
Fri 14 May 2021 - 07:19:pm (Sydney)

DXB Share Price

DIMERIX LIMITEDDXBPharmaceuticals, Biotechnology & Life Sciences

DXB Company Information


Dimerix Limited





GIC Industry:


GIC Sub Industry:



425 Smith Street Fitzroy VIC Australia 3065


61 3 0081 3321

Exec. Chairman:

Dr. James Howard Williams M.B.A., BSc (Hons), Ph.D., MBA, GAICD

CEO, MD & Director:

Dr. Nina Webster Ph.D., M.IP.Law, MBA

CFO & Company Sec.:

Mr. Hamish George B.Com., C.A.

Chief Scientific Advisor:

Mr. Kevin Donald George Pfleger BA (Hons), MA, Ph.D.

Bus. Devel. Officer:

Ms. Elizabeth McCall B.Com., L.L.B., LLB., B.Juris, B.Com(Hons), GAICD

Company Overview:

Dimerix Limited, a biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. It offers DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis; and DMX-700, which is in pre-clinical stage for the treatment of chronic obstructive pulmonary disease, as well as proprietary ReceptorHIT assay technology. The company was incorporated in 1975 and is headquartered in Fitzroy, Australia.

DXB Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


DXB CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


DXB Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


Total Revenue:


DXB Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


DXB Share Price History

DXB News

01 Feb, 2021
Nina Webster has been the CEO of Dimerix Limited ( ASX:DXB ) since 2018, and this article will examine the executive's...
29 Jul, 2020
Dimerix reported excellent results from the clinical trial of drug DMX-200 aimed at rare kidney disease focal segmental glomerulosclerosis (FSGS)